What is the maximum safe dose of bupivacaine 0.25% (2.5 mg/mL) for an adult, with and without epinephrine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Maximum Safe Dose of Bupivacaine 0.25%

For adults, the maximum safe dose of bupivacaine 0.25% is 175 mg (70 mL) without epinephrine and 225 mg (90 mL) with epinephrine 1:200,000 for a single administration. 1

Dosing Framework

The FDA-approved dosing limits are clearly defined in the drug label:

  • Without epinephrine: Up to 175 mg per single dose
  • With epinephrine: Up to 225 mg per single dose
  • Repeat dosing: May be repeated once every 3 hours
  • Maximum daily dose: 400 mg in 24 hours 1

Volume Calculations for 0.25% Bupivacaine (2.5 mg/mL)

  • Without epinephrine: 175 mg ÷ 2.5 mg/mL = 70 mL maximum
  • With epinephrine: 225 mg ÷ 2.5 mg/mL = 90 mL maximum

Critical Safety Considerations

Always use the lowest effective dose - the maximum doses represent upper limits, not target doses. The actual dose should be individualized based on:

  • Patient size and physical status (reduce for elderly/debilitated patients)
  • Cardiac or liver disease (requires dose reduction)
  • Injection site vascularity (highly vascular areas increase systemic absorption)
  • Procedure duration and complexity 1

Preventing Local Anesthetic Systemic Toxicity (LAST)

The following steps are mandatory to minimize toxicity risk:

  • Aspirate before each injection to avoid intravascular injection
  • Use incremental injections rather than bolus dosing
  • Continuously monitor and communicate with the patient for early toxicity signs
  • Avoid rapid injection of large volumes 2

Context from Clinical Practice

Recent literature demonstrates that practitioners frequently exceed package insert limits, particularly with continuous infusions. A 2024 review found that 51% of bupivacaine infusions exceeded recommended limits, with toxicity occurring in patients receiving high 24-hour doses, bilateral catheters, or those with cytochrome P-450 inhibitors and hypoalbuminemia 3. This underscores the importance of adhering to single-dose limits and carefully monitoring cumulative exposure.

The toxic threshold for bupivacaine is 1500-4500 ng/mL plasma concentration 4, which can occur with doses well below the maximum when risk factors are present.

Special Populations

  • Elderly/debilitated patients: Reduce standard doses
  • Cardiac disease: Reduce standard doses
  • Hepatic disease: Reduce standard doses and extend dosing intervals
  • Pediatric patients <12 years: Bupivacaine is not recommended 1

References

2
Guideline

guidelines for the use of local anesthesia in office-based dermatologic surgery.

Journal of the American Academy of Dermatology, 2016

Related Questions

What is the maximum safe single dose of bupivacaine (including limits with and without epinephrine) for an adult patient?
What are the recommended maximum doses of bupivacaine for adults (with and without epinephrine) for different administration routes such as local infiltration, peripheral nerve block, epidural analgesia, and spinal anesthesia?
What is the appropriate concentration and maximum dose of bupivacaine for subcutaneous infiltration in an adult patient without amide‑type anesthetic allergy?
Can repeated exposure to general anesthesia (general anesthetic) cause adverse effects?
What is the minimum time interval to repeat bupivacaine (local anesthetic) 2 milligrams/kilogram (mg/kg) for regional anesthesia?
Can diazepam be administered six hours after olanzapine?
What is the maximum safe single dose of bupivacaine (including limits with and without epinephrine) for an adult patient?
In a patient receiving chronic glucocorticoid therapy, what additional medications should be prescribed besides calcium and vitamin D?
What is the recommended dosing of fluticasone nasal spray (Flonase) for allergic rhinitis in adults/adolescents (≥12 years) and children (4–11 years)?
What is the appropriate management for an adult patient with a hepatic hemangioma who presents with pneumonia and a pleural effusion?
What medications are recommended for severe sleepwalking?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.